Stock Groups

Tokyo Kikai shareholders approve poison pill, setting up court battle -Breaking


© Reuters. FILE PHOTO – The Tokyo Kikai Seisakusho Ltd. logo is on display at Tokyo’s headquarters in Tokyo (Japan), October 21st, 2021. REUTERS/Issei Kato/File Photo

Makiko Yamazaki

TOKYO (Reuters – Tokyo Kikai Seisakusho Ltd shares approved a “poison tablet” measure Friday to stop a takeover by the top investor. It will lead to a battle in court that could result in major implications for Japan’s hostile bidders.

Tokyo Kikai (a relatively unknown company) said that the majority of shareholders supported a plan to reduce Asia Development Capital’s 40% stake.

ADC was excluded https://www.reuters.com/business/sustainable-business/court-battle-raises-question-how-far-will-japan-swallow-poison-pills-2021-10-21 from the vote and has already sought an injunction to nullify it. ADC could have been victorious if the investors had voted for it on Friday.

Tokyo Kikai stated in a statement that 79% supported the poison pill. ADC claimed that Tokyo Kikai would be defeated if ADC were not included, because the numbers of poison pill votes received were less than ADC could.

The injunction will now be discussed.

Tokyo Kikai’s victory could make it more difficult for Japanese companies to take poison pills.

Tokyo Kikai claims ADC damages its corporate value. The fund counters that Tokyo Kikai would be in favour of shareholders equality.

It highlights both an increase in hostile takeovers of Japan over the last few years, and what many experts view as insufficient takeover regulations that leave smaller companies without any defenses against hostile offers.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. Because prices might not reflect the market, they may be incorrect. This means that prices cannot be considered indicative and are inappropriate for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.